Cited by 783Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatmentsHereditary Neurological Disorders

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Open access

Haidet-Phillips, Amanda M, Hester, Mark E, Miranda, Carlos J, Meyer, Kathrin, Braun, Lyndsey, Frakes, Ashley, Song, SungWon, Likhite, Shibi, Murtha, Matthew J, Foust, Kevin D, Rao, Meghan, Eagle, Amy, Kammesheidt, Anja, Christensen, Ashley, Mendell, Jerry R, Burghes, Arthur H M, Kaspar, Brian K·2011·Nature Biotechnology

DOI 10.1038/nbt.1957PMC PMC3170425

Open this paper in CoChat — free account

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease, with astrocytes implicated as contributing substantially to motor neuron death in familial (F)ALS. However, the proposed role of astrocytes in the pathology of ALS derives in part from rodent models of FALS based upon dominant mutations within the superoxide dismutase 1 (SOD1) gene, which account for <2% of all ALS cases. Their role in sporadic (S)ALS, which affects >90% of ALS patients, remains to be established. Using astrocytes generated from postmortem tissue from both FALS and SALS patients, we show that astrocytes derived from both patient groups are similarly toxic to motor neurons. We also demonstrate that SOD1 is a viable target for SALS, as its knockdown significantly attenuates astrocyte-mediated toxicity toward motor neurons. Our data highlight astrocytes as a non-cell autonomous component in SALS and provide an in vitro model system to investigate common disease mechanisms and evaluate potential therapies for SALS and FALS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt.1957

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W. K., Croft, G. F., Saphier, G., Leibel, R. L., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 2,019
Directed differentiation of embryonic stem cells into motor neurons.
Wichterle, H., Lieberam, I., Porter, J. A., & Jessell, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00835-8 · Cited by 1,792
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · cited 1×
“Recently, novel vectors have been shown to efficiently target astrocytes of adult brain and spinal cor”
BackgroundSelf-citation
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W. T., Siwek, D. F., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,131

Flagged first, then by citations

Show all 30 references

Sorted by citations

Items 401–500 of 783

Astrocytes: Dissecting Their Diverse Roles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Valori, C. F., Sulmona, C., Brambilla, L., & Rossi, D. (2023) · Cells · doi:10.3390/cells12111450 · Cited by 30
Phenotypic heterogeneity of astrocytes in motor neuron disease
Trías, E., Barbeito, L., & Yamanaka, K. (2018) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12476 · Cited by 31
Immunology of amyotrophic lateral sclerosis – role of the innate and adaptive immunity
Mimic, S., Aru, B., Pehlivanoğlu, C., Sleiman, H., Anđjus, P. R., & Demirel, G. Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1277399 · Cited by 29
Adipose-derived stem cells protect motor neurons and reduce glial activation in both in vitro and in vivo models of ALS
Ciervo, Y., Gatto, N., Allen, C. F., Grierson, A. J., Ferraiuolo, L., Mead, R. J., & Shaw, P. J. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.03.017 · Cited by 29
The Cell Autonomous and Non-Cell Autonomous Aspects of Neuronal Vulnerability and Resilience in Amyotrophic Lateral Sclerosis
Schweingruber, C., & Hedlund, E. (2022) · Biology · doi:10.3390/biology11081191 · Cited by 29
A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model
Tanaka, K., Kanno, T., Yanagisawa, Y., Yasutake, K., Inoue, S., Hirayama, N., & Ikeda, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087728 · Cited by 29
New In Vitro Models to Study Amyotrophic Lateral Sclerosis
Myszczynska, M. A., & Ferraiuolo, L. (2016) · Brain Pathology · doi:10.1111/bpa.12353 · Cited by 31
Ultrastructural features of aberrant glial cells isolated from the spinal cord of paralytic rats expressing the amyotrophic lateral sclerosis-linked SOD1G93A mutation
Jiménez, M., Díaz‐Amarilla, P., Isasi, E., Casanova, G., Barbeito, L., & Olivera‐Bravo, S. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2681-1 · Cited by 34
BMP-Responsive Protease HtrA1 Is Differentially Expressed in Astrocytes and Regulates Astrocytic Development and Injury Response
Chen, J., Gulden, S. V., McGuire, T. L., Fleming, A. C., Oka, C., Kessler, J. A., & Peng, C. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2031-17.2018 · Cited by 28
Pathological Roles of Wild-Type Cu, Zn-Superoxide Dismutase in Amyotrophic Lateral Sclerosis
Furukawa, Y. (2012) · Neurology Research International · doi:10.1155/2012/323261 · Cited by 30
Comprehensive analysis to explain reduced or increased SOD1 enzymatic activity in ALS patients and their relatives
Keskin, I., Birve, A., Berdyński, M., Hjertkvist, K., Rofougaran, R., Nilsson, T., Glass, J. D., Marklund, S. L., & Andersen, P. M. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1301481 · Cited by 28
The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening
Gonzalez, D. M., Gregory, J. K., & Brennand, K. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00117 · Cited by 26
A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse model
Tsuburaya, N., Homma, K., Higuchi, T., Balia, A. G., Yamakoshi, H., Shibata, N., Nakamura, S., Nakagawa, H., Ikeda, S., Umezawa, N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05127-2 · Cited by 29
The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review
Erber, A. C., Çetin, H., Berry, D., & Schernhammer, E. S. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1702549 · Cited by 28
Endogenous prion protein conversion is required for prion‐induced neuritic alterations and neuronal death
Cronier, S., Carimalo, J., Schaeffer, B., Jaumain, E., Béringue, V., Miquel, M., Laude, H., & Peyrin, J. (2012) · The FASEB Journal · doi:10.1096/fj.11-201772 · Cited by 28
Neuroinflammation and Neurodegeneration
Morales, I., Farias, G. A., Cortés, N., & Maccioni, R. B. (2016) · InTech eBooks · doi:10.5772/64545 · Cited by 34
Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs
Halpern, M., Brennand, K., & Gregory, J. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104562 · Cited by 30
Generation of motor neurons from pluripotent stem cells
Chipman, P. H., Toma, J. S., & Rafuse, V. F. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59544-7.00015-9 · Cited by 27
RNA quality control and protein aggregates in amyotrophic lateral sclerosis: A review
Verma, A. K., & Tandan, R. (2012) · Muscle & Nerve · doi:10.1002/mus.23673 · Cited by 27
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression
Bonifacino, T., Rebosio, C., Provenzano, F., Torazza, C., Balbi, M., Milanese, M., Raiteri, L., Usai, C., Fedele, E., & Bonanno, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184552 · Cited by 27
Identification of Genetic Modifiers of TDP-43: Inflammatory Activation of Astrocytes for Neuroinflammation
Kim, J., Rahman, M. H., Park, D., Jo, M., Kim, H.-J., & Suk, K. (2021) · Cells · doi:10.3390/cells10030676 · Cited by 27
A seeded propagation of Cu, Zn-superoxide dismutase aggregates in amyotrophic lateral sclerosis
Ogawa, M., & Furukawa, Y. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00083 · Cited by 27
Glia: an emerging target for neurological disease therapy
Almad, A. A., & Maragakis, N. J. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt128 · Cited by 27
15-Deoxy-Δ12,14-prostaglandin J2 promotes phosphorylation of eukaryotic initiation factor 2α and activates the integrated stress response
Tauber, D., & Parker, R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007138 · Cited by 25
The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tension
Keskin, I., Forsgren, E., Lehmann, M., Andersen, P. M., Brännström, T., Lange, D. J., Synofzik, M., Nordström, U., Zetterström, P., Marklund, S. L., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01986-1 · Cited by 27
Recent Advances in Extracellular Vesicles in Amyotrophic Lateral Sclerosis and Emergent Perspectives
Afonso, G. J. M., Cavaleiro, C., Valero, J., Mota, S. I., & Ferreiro, E. B. (2023) · Cells · doi:10.3390/cells12131763 · Cited by 28
Studying ALS: Current Approaches, Effect on Potential Treatment Strategy
Ustyantseva, E., Medvedev, S. P., & Zakian, S. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-41283-8_11 · Cited by 26
Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies
Gittings, L. M., & Sattler, R. (2020) · Faculty Reviews · doi:10.12703/b/9-12 · Cited by 27
Increased Axon Initial Segment Length Results in Increased Na+ Currents in Spinal Motoneurones at Symptom Onset in the G127X SOD1 Mouse Model of Amyotrophic Lateral Sclerosis
Jørgensen, H. S., Jensen, D. B., Dimintiyanova, K. P., Bonnevie, V. S., Hedegaard, A., Lehnhoff, J., Moldovan, M., Grøndahl, L., & Meehan, C. F. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.11.016 · Cited by 26
Investigation of Risperidone Treatment Associated With Enhanced Brain Activity in Patients Who Stutter
Maguire, G. A., Yoo, B. R., & SheikhBahaei, S. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.598949 · Cited by 28
Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment
Arslanbaeva, L. R., & Bisaglia, M. (2022) · Molecules · doi:10.3390/molecules27051471 · Cited by 27
Pathogenic Extracellular Vesicle (EV) Signaling in Amyotrophic Lateral Sclerosis (ALS)
Kim, G., Chen, X., & Yang, Y. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01232-9 · Cited by 26
Defects of Nutrient Signaling and Autophagy in Neurodegeneration
Ondaro, J., Hernández-Eguiazu, H., Garciandia-Arcelus, M., Loera‐Valencia, R., Rodríguez-Gómez, L., Jiménez-Zúñiga, A., Goikolea, J., Rodriguez‐Rodriguez, P., Ruiz‐Martínez, J., Moreno, F., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.836196 · Cited by 28
Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors
Holmqvist, S., Brouwer, M., Djelloul, M., Diaz, A. G., Devine, M. J., Hammarberg, A., Fog, K., Kunath, T., & Roybon, L. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.05.014 · Cited by 26
Muscle‐restricted nuclear receptor interaction protein knockout causes motor neuron degeneration through down‐regulation of myogenin at the neuromuscular junction
Chen, H., Tsai, L., Liao, K., Wu, T., Huang, Y., Huang, Y., Chang, S., Wang, P., Tsao, Y., & Chen, S. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12299 · Cited by 26
Glial Cells as Emerging Therapeutic Targets in Neurodegenerative Diseases: Mechanistic Insights and Translational Perspectives
Vishnumukkala, T., Nassir, C. M. N. C. M., Hein, Z. M., Gopalakrishna, P. K., Karikalan, B., Alkatiri, A., Jagadeesan, S., Naik, V. R., Thomas, W., Moklas, M. A. M., et al. (2025) · Cells · doi:10.3390/cells14191497 · Cited by 30
Advances in Reprogramming-Based Study of Neurologic Disorders
Nityanandam, A., & Baldwin, K. K. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0044 · Cited by 25
Arylazanylpyrazolone Derivatives as Inhibitors of Mutant Superoxide Dismutase 1 Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis
Zhang, Y., Benmohamed, R., Huang, H., Chen, T., Voisine, C., Morimoto, R. I., Kirsch, D. R., & Silverman, R. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400079a · Cited by 24
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Ravera, S., Bonifacino, T., Bartolucci, M., Milanese, M., Gallia, E., Provenzano, F., Cortese, K., Panfoli, I., & Bonanno, G. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1059-z · Cited by 25
Neuronal–glial communication perturbations in murine SOD1G93A spinal cord
MacLean, M., López‐Díez, R., Vásquez, C., Gugger, P. F., & Schmidt, A. M. (2022) · Communications Biology · doi:10.1038/s42003-022-03128-y · Cited by 25
Stem cell therapy for amyotrophic lateral sclerosis
Mao, Z., Zhang, S., & Chen, H. (2015) · Cell Regeneration · doi:10.1186/s13619-015-0026-7 · Cited by 25
Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis
Gubert, F., Decotelli, A. B., Bonacossa-Pereira, I., Figueiredo, F. R., Zaverucha-do-Valle, C., Tovar-Moll, F. F., Hoffmann, L., Urmenyi, T. P., Santiago, M. F., & Méndez‐Otero, R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0293-4 · Cited by 25
Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis
Zhang, Y., Zhao, K. T., Fox, S. G., Kim, J.-H., Kirsch, D. R., Ferrante, R. J., Morimoto, R. I., & Silverman, R. B. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00561 · Cited by 24
Small Molecule Inhibition of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4)
Genung, N. E., & Guckian, K. M. (2017) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2016.11.004 · Cited by 25
Astrocyte elevated gene-1 is a novel regulator of astrogliosis and excitatory amino acid transporter-2 via interplaying with nuclear factor-κB signaling in astrocytes from amyotrophic lateral sclerosis mouse model with hSOD1 G93A mutation
Yin, X. L., Wang, S., Qi, Y., Wang, X., Jiang, H., Wang, T., Yang, Y., Wang, Y., Zhang, C., & Feng, H. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.05.004 · Cited by 25
The Role of Glia in Canine Degenerative Myelopathy: Relevance to Human Amyotrophic Lateral Sclerosis
Gołubczyk, D., Małysz‐Cymborska, I., Kalkowski, L., Janowski, M., Coates, J. R., Wojtkiewicz, J., Maksymowicz, W., & Walczak, P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1488-3 · Cited by 25
Imaging Neurochemistry and Brain Structure Tracks Clinical Decline and Mechanisms of ALS in Patients
Andronesi, O. C., Nicholson, K. A., Jafari‐Khouzani, K., Bogner, W., Wang, J., Chan, J. G. M., Macklin, E. A., Levine, M., Breen, C. T., Schwarzschild, M. A., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.590573 · Cited by 23
Could sirtuin activities modify ALS onset and progression?
Tang, B. L. (2017) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0452-2 · Cited by 24
Exploring the properties and potential of the neural extracellular matrix for next‐generation regenerative therapies
Ortega, J. A., de Aguiar, G. P. S., Chandravanshi, P., Levy, N., Engel, E., & Álvarez, Z. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1962 · Cited by 27
RNA-targeted Therapeutics for ALS
Reddy, L. V., & Miller, T. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0344-z · Cited by 26
Retrospective Observational Study and Analysis of Two Different Photobiomodulation Therapy Protocols Combined with Rehabilitation Therapy as Therapeutic Interventions for Canine Degenerative Myelopathy
Miller, L. A., Torraca, D., & Taboada, L. H. D. (2020) · Photobiomodulation Photomedicine and Laser Surgery · doi:10.1089/photob.2019.4723 · Cited by 24
Endoplasmic Reticulum Interaction Supports Energy Production and Redox Homeostasis in Mitochondria Released from Astrocytes
Park, J., Lo, E. H., & Hayakawa, K. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00892-7 · Cited by 24
Mini-Review: Induced pluripotent stem cells and the search for new cell-specific ALS therapeutic targets
Ferraiuolo, L., & Maragakis, N. J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135911 · Cited by 28
Autophagy‐Mediated Inflammatory Cytokine Secretion in Sporadic ALS Patient iPSC‐Derived Astrocytes
BaofengFeng, Amponsah, A. E., Guo, R., Liu, X., Zhang, J., Du, X., Zhou, Z., He, J., Ma, J., & Cui, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6483582 · Cited by 24
Protein kinase B (AKT) upregulation and Thy-1-αvβ3 integrin-induced phosphorylation of Connexin43 by activated AKT in astrogliosis
Pérez-Núñez, R., Chamorro, A., González, M. F., Contreras, P., Artigas, R., Corvalán, A. H., van Zundert, B., Reyes, C., Moya, P. R., Avalos, A. M., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02677-7 · Cited by 24
A Chemical Chaperone‐Based Drug Candidate is Effective in a Mouse Model of Amyotrophic Lateral Sclerosis (ALS)
Getter, T., Zaks, I., Barhum, Y., Ben‐Zur, T., Böselt, S., Gregoire, S., Viskind, O., Shani, T., Gottlieb, H. E., Green, O., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500045 · Cited by 24
Advances in Cellular Models to Explore the Pathophysiology of Amyotrophic Lateral Sclerosis
Veyrat‐Durebex, C., Corcia, P., Dangoumau, A., Laumonnier, F., Piver, É., Gordon, P. H., Andres, C. R., Vourc’h, P., & Blasco, H. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8573-9 · Cited by 28
Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis
Stoica, L., & Sena‐Esteves, M. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00056 · Cited by 24
Stem cells for amyotrophic lateral sclerosis modeling and therapy: Myth or fact?
Coatti, G. C., Beccari, M. S., Olávio, T. R., Mitne‐Neto, M., Okamoto, O. K., & Zatz, M. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22630 · Cited by 23
Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis
Rué, L., Oeckl, P., Timmers, M., Lenaerts, A., van der Vos, J., Smolders, S., Poppe, L., de Boer, A., Bosch, L. V. D., Damme, P. V., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0759-6 · Cited by 23
Structural analysis of the overoxidized Cu/Zn-superoxide dismutase in ROS-induced ALS filament formation
Baek, Y., Woo, T., Ahn, J., Lee, D., Kwon, Y., Park, B.-J., & Ha, N. (2022) · Communications Biology · doi:10.1038/s42003-022-04017-0 · Cited by 23
Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
Lorenzini, I., Alsop, E. B., Levy, J., Gittings, L. M., Lall, D., Rabichow, B. E., Moore, S. R., Pevey, R. S., Bustos, L. M., Burciu, C., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1179796 · Cited by 34
Human glial progenitor engraftment and gene expression is independent of the ALS environment
Haidet-Phillips, A. M., Doreswamy, A., Gross, S. K., Tang, X., Campanelli, J. T., & Maragakis, N. J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.12.011 · Cited by 24
Self-citation
Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1 mutant mice
Bakshi, R., Xu, Y., Mueller, K. A., Chen, X., Granucci, E. J., Paganoni, S., Sadri‐Vakili, G., & Schwarzschild, M. A. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.06.002 · Cited by 24
Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis
Korhonen, P., Pollari, E., Kanninen, K. M., Savchenko, E., Lehtonen, Š., Wojciechowski, S., Pomeshchik, Y., Bosch, L. V. D., Goldsteins, G., Koıstınaho, J., et al. (2019) · IBRO Reports · doi:10.1016/j.ibror.2019.01.005 · Cited by 24
A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications
Nakagawa, Y., & Yamada, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173737 · Cited by 23
Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS
Zhang, Y., Benmohamed, R., Zhang, W., Kim, J.-H., Edgerly, C. K., Zhu, Y., Morimoto, R. I., Ferrante, R. J., Kirsch, D. R., & Silverman, R. B. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3000963 · Cited by 23
Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patients
Xie, Q., Li, K., Chen, Y., Li, Y., Jiang, W., Cao, W., Yu, H., Fan, D., & Deng, B. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00477-6 · Cited by 27
The Diverse Roles of Reactive Astrocytes in the Pathogenesis of Amyotrophic Lateral Sclerosis
Yang, K., Liu, Y., & Zhang, M. (2024) · Brain Sciences · doi:10.3390/brainsci14020158 · Cited by 29
Current potential therapeutics of amyotrophic lateral sclerosis
Lu, L., Deng, Y., & Xu, R. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1402962 · Cited by 26
Multimodal Synchrotron Radiation Microscopy of Intact Astrocytes from the hSOD1 G93A Rat Model of Amyotrophic Lateral Sclerosis
Dučić, T., Stamenković, S., Lai, B. C. H., Anđjus, P. R., & Lučić, V. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04273 · Cited by 22
Inhibitory Dysfunction in Amyotrophic Lateral Sclerosis: Future Therapeutic Opportunities
Clark, R. M., Blizzard, C. A., & Dickson, T. C. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.49 · Cited by 23
Chronic infusion of SOD1G93A astrocyte‐secreted factors induces spinal motoneuron degeneration and neuromuscular dysfunction in healthy rats
Ramírez-Jarquín, U. N., Rojas, F., van Zundert, B., & Tapia, R. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25827 · Cited by 22
HSPB1 mutations causing hereditary neuropathy in humans disrupt non-cell autonomous protection of motor neurons
Heilman, P. L., Song, S., Miranda, C. J., Meyer, K., Srivastava, A. K., Knapp, A., Wier, C. G., Kaspar, B. K., & Kolb, S. J. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.002 · Cited by 22
Self-citation
Arctigenin derivative A‐1 ameliorates motor dysfunction and pathological manifestations in SOD1 G93A transgenic mice via the AMPK / SIRT1 / PGC ‐1α and AMPK / SIRT1 / IL ‐1β/ NF‐κB pathways
Xiong, B., Yang, C., Yang, X., Luo, S., Li, S., Chen, C., He, K., Nie, L., Li, P., Li, S., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14692 · Cited by 21
Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited
Rodríguez, M. J., & Mahy, N. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867324666161123091314 · Cited by 22
Sigma-1 Receptor in Motoneuron Disease
Mancuso, R., & Navarro, X. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50174-1_16 · Cited by 22
Contributions of Drug Transporters to Blood-Brain Barriers
Liu, L., & Liu, X. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-7647-4_9 · Cited by 21
The prion-like nature of amyotrophic lateral sclerosis
McAlary, L., Yerbury, J. J., & Cashman, N. R. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.07.002 · Cited by 21
Why should we care about astrocytes in a motor neuron disease?
Dittlau, K. S., & Bosch, L. V. D. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1047540 · Cited by 24
Altered Metabolic Profiles Associate with Toxicity in SOD1G93A Astrocyte-Neuron Co-Cultures
Valbuena, G. N., Tortarolo, M., Bendotti, C., Cantoni, L., & Keun, H. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-00072-4 · Cited by 24
The gut microbiome and neuroinflammation in amyotrophic lateral sclerosis? Emerging clinical evidence
Fournier, C. N., Houser, M. C., Tansey, M. G., Glass, J. D., & Hertzberg, V. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.007 · Cited by 21
An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS
Dong, Q.-X., Zhu, J., Liu, S., Yu, X., & Liu, R. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.032 · Cited by 21
Nonmuscle myosin IIA and IIB differentially modulate migration and alter gene expression in primary mouse tumorigenic cells
Halder, D., Saha, S., Singh, R. K., Ghosh, I., Mallick, D., Dey, S. K., Ghosh, A., Das, B. B., Ghosh, S., & Jana, S. S. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e18-12-0790 · Cited by 21
Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis
Clark, C. M., Clark, R. M., Hoyle, J. A., & Dickson, T. C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15125 · Cited by 20
Heterogeneity of Neuroinflammatory Responses in Amyotrophic Lateral Sclerosis: A Challenge or an Opportunity?
Cipollina, G., Serej, A. D., Nolfi, G. D., Gazzano, A., Marsala, A., Spatafora, M. G., & Peviani, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217923 · Cited by 20
Remodeling of astrocyte secretome in amyotrophic lateral sclerosis: uncovering novel targets to combat astrocyte-mediated toxicity
Ng, W., & Ng, S. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00332-y · Cited by 23
The Role of Mitochondrial Biogenesis in Ischemic Stroke
Shademan, B., Avcı, Ç. B., Karamad, V., Soureh, G. J., Olia, J. B. H., Esmaily, F., Nourazarian, A., & Nikanfar, M. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2204088 · Cited by 22
The non-cell-autonomous component of ALS: new in vitro models and future challenges
Ferraiuolo, L. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140168 · Cited by 21
Immunoglobulins G from patients with sporadic amyotrophic lateral sclerosis affects cytosolic Ca2+ homeostasis in cultured rat astrocytes
Milosevic, M. M., Stenovec, M., Kreft, M., Petrušić, V., Stević, Z., Trkov, S., Anđjus, P. R., & Zorec, R. (2013) · Cell Calcium · doi:10.1016/j.ceca.2013.03.005 · Cited by 20
Different Human Copper-Zinc Superoxide Dismutase Mutants, SOD1G93A and SOD1H46R, Exert Distinct Harmful Effects on Gross Phenotype in Mice
Pan, L., Yoshii, Y., Otomo, A., Ogawa, H. K., Iwasaki, Y., Shang, H., & Hadano, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033409 · Cited by 20
Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies
Ido, A., Fukuyama, H., & Urushitani, M. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12106980 · Cited by 20
Astrocytes in Motor Neuron Diseases
Valori, C. F., Guidotti, G., Brambilla, L., & Rossi, D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_10 · Cited by 19
Astrocytes in Amyotrophic Lateral Sclerosis
Vaz, S. H., Pinto, S., Sebastião, A. M., & Brites, D. M. T. O. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.amyotrophiclateralsclerosis.astrocytes.2021 · Cited by 21
MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis
Glajch, K. E., Ferraiuolo, L., Mueller, K. A., Stopford, M. J., Prabhkar, V., Gravanis, A., Shaw, P. J., & Sadri‐Vakili, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164103 · Cited by 20
Imaging of glial cell morphology, SOD1 distribution and elemental composition in the brainstem and hippocampus of the ALS hSOD1G93A rat
Stamenković, S., Dučić, T., Stamenković, V., Kranz, A., & Anđjus, P. R. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.041 · Cited by 19
Amyotrophic lateral sclerosis as a protein level, non-genomic disease: Therapy with S2RM exosome released molecules
Maguire, G. (2017) · World Journal of Stem Cells · doi:10.4252/wjsc.v9.i11.187 · Cited by 23
Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse model
Baird, M., Likhite, S. B., Vetter, T. A., Caporale, J. R., Girard, H. B., Roussel, F. S., Howard, A. E., Schwartz, M. K., Reed, A. R., Kaleem, A., et al. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101312 · Cited by 19
Self-citation
Cortical astroglia undergo transcriptomic dysregulation in the G93A SOD1 ALS mouse model
Miller, S., Glatzer, J. C., Hsieh, Y.-C., & Rothstein, J. D. (2018) · Journal of Neurogenetics · doi:10.1080/01677063.2018.1513508 · Cited by 19
Aberrant NLRP3 Inflammasome Activation Ignites the Fire of Inflammation in Neuromuscular Diseases
Péladeau, C. L., & Sandhu, J. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116068 · Cited by 20

Authors: Haidet-Phillips, A. M., Hester, M. E., Miranda, C. J., Meyer, K., Braun, L., Frakes, A., Song, S., Likhite, S., Murtha, M. J., Foust, K. D., Rao, M., Eagle, A., Kammesheidt, A., Christensen, A., Mendell, J. R., Burghes, A. H. M., & Kaspar, B. K.
Affiliations: Nationwide Children's Hospital (US)
Ambry Genetics (United States) (US)
The Ohio State University (US)
Corresponding author: Kaspar, Brian K
ORCID: Hester, Mark E
Miranda, Carlos J
Meyer, Kathrin
Likhite, Shibi
Foust, Kevin D
Mendell, Jerry R
Burghes, Arthur H M
Kaspar, Brian K
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2011-08-10
Volume: 29
Issue: 9
Pages: 824-828
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.1957
PMC: PMC3170425
OpenAlex: W2059355164
Cited by: 782
References: 30
Citations by year: 2026: 21 · 2025: 29 · 2024: 43 · 2023: 38 · 2022: 54 · 2021: 46 · 2020: 68 · 2019: 59 · 2018: 55 · 2017: 58 · 2016: 66 · 2015: 59 · 2014: 70 · 2013: 59 · 2012: 50
FWCI: 37.69
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of Neurological Disorders and Stroke (RC2NS069476, R01 NS644912-1A1, RC2 NS69476-01, R01NS064492, T32NS077984, F31NS058224)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords: amyotrophic lateral sclerosis, astrocytes, motor neuron toxicity, sporadic ALS, familial ALS, SOD1, disease mechanisms
MeSH terms: Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Astrocytes, Cell Differentiation, Cell Line, Disease Models, Animal, Gene Expression Regulation, Humans, Immunohistochemistry, Motor Neurons, Mutation, Superoxide Dismutase, Signal Transduction, Biomarkers, Sequence Analysis, DNA, Coculture Techniques, Mice, Embryonic Stem Cells, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks